AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16045573 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid-suppression duodenal diversion procedures (truncal vagotomy-partial gastrectomy plus Roux-en-Y gastrojejunostomy)
Number of subjects: 73
Study 12161837 — intervention group
Group type: EXPERIMENTAL
Intervention: Paretic limb during rising from a chair
Number of subjects: 15
Study 12161837 — intervention group
Group type: COMPARATOR
Intervention: Nonparetic limb during rising from a chair
Number of subjects: 15
Study 12161837 — intervention group
Group type: EXPERIMENTAL
Intervention: Paretic limb during forward weight-shifting
Number of subjects: 15
Study 12161837 — intervention group
Group type: COMPARATOR
Intervention: Nonparetic limb during forward weight-shifting
Number of subjects: 15
Study 12161837 — intervention group
Group type: EXPERIMENTAL
Intervention: All 5 standing tasks
Number of subjects: 15
Study 10385765 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1 g intravenously infused 6 to 12 hours before stenting)
Number of subjects: 140
Study 10385765 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intravenously infused 6 to 12 hours before stenting)
Number of subjects: 140
Study 10385765 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 140
Study 10385765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 8625084 — intervention group
Group type: EXPERIMENTAL
Intervention: Helium-neon laser treatment
Number of subjects: 20
Study 8625084 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (control)
Number of subjects: 20
Study 2205527 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (400 mg per day for 5 days)
Number of subjects: 39
Study 2205527 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole (80 mg per day for 5 days, 120 mg on the 1st day)
Number of subjects: 39
Study 2205527 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine followed by Omeprazole
Number of subjects: 39
Study 6796711 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term enteral nutritional support (12 months)
Number of subjects: 0
Study 6796711 — intervention group
Group type: COMPARATOR
Intervention: Standard parameters of nutritional assessment
Number of subjects: 0
Study 31050930 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensibilize KF 2%
Number of subjects: 60
Study 31050930 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinpro XT Varnish
Number of subjects: 60
Study 31050930 — intervention group
Group type: EXPERIMENTAL
Intervention: Photon Lase III (100 mW, 4 J/cm2‐1 J/cm2 each point, 10 sec per point with wavelength of 808 nm)
Number of subjects: 60
Study 28387846 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized feedback intervention
Number of subjects: 79
Study 28387846 — intervention group
Group type: COMPARATOR
Intervention: Educational session (Control)
Number of subjects: 79
Study 25889459 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency feedback group (HFF group; N=23)
Number of subjects: 47
Study 25889459 — intervention group
Group type: COMPARATOR
Intervention: Low-frequency feedback group (LFF group; N=24)
Number of subjects: 47
Study 22791282 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum for 6 months
Number of subjects: 204
Study 22791282 — intervention group
Group type: COMPARATOR
Intervention: Non-xylitol treatment
Number of subjects: 204
Study 21956721 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (155 U, 31 injections of 5U each, with an additional 40 U as needed)
Number of subjects: 1384
Study 21956721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1384
Study 19695562 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive, multimedia online training (OLT)
Number of subjects: 150
Study 19695562 — intervention group
Group type: EXPERIMENTAL
Intervention: Two‐day instructor‐led training workshop (ILT)
Number of subjects: 150
Study 19695562 — intervention group
Group type: COMPARATOR
Intervention: Written treatment manual
Number of subjects: 150
Study 17146104 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin plus antidepressant
Number of subjects: 118
Study 17146104 — intervention group
Group type: COMPARATOR
Intervention: Gabapentin alone
Number of subjects: 118
Study 15179390 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment with either a headgear or a functional appliance
Number of subjects: 0
Study 15179390 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment
Number of subjects: 0
Study 15179390 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 0
Study 11209119 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential pulse therapy with itraconazole (200 mg twice daily for 1 week) followed by terbinafine (250 mg twice daily for 1 week)
Number of subjects: 190
Study 11209119 — intervention group
Group type: COMPARATOR
Intervention: Terbinafine pulse therapy (3 or 4 pulses of terbinafine)
Number of subjects: 190
Study 10095974 — intervention group
Group type: EXPERIMENTAL
Intervention: Spermicidal film
Number of subjects: 58
Study 10095974 — intervention group
Group type: COMPARATOR
Intervention: No method
Number of subjects: 58
Study 10095974 — intervention group
Group type: EXPERIMENTAL
Intervention: Male latex condom
Number of subjects: 58
Study 8064960 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sinus surgery (ESS)
Number of subjects: 77
Study 8064960 — intervention group
Group type: COMPARATOR
Intervention: Caldwell-Luc operation
Number of subjects: 77
Study 3310196 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy (ST)
Number of subjects: 107
Study 3310196 — intervention group
Group type: COMPARATOR
Intervention: Control (vasopressin/balloon tamponade)
Number of subjects: 107
Study 28701030 — intervention group
Group type: EXPERIMENTAL
Intervention: Crizotinib
Number of subjects: 314
Study 28701030 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 314
Study 28967523 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine-human reassortant pentavalent rotavirus vaccine (BRV-PV)
Number of subjects: 7499
Study 28967523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7499
Study 27313413 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasa Avaleha (VA)
Number of subjects: 66
Study 27313413 — intervention group
Group type: EXPERIMENTAL
Intervention: Granules of Vasa Avaleha (GVA)
Number of subjects: 66
Study 22977265 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus Control (SC) training (30-min time- and place-restricted worry period each day for 2 weeks)
Number of subjects: 53
Study 22977265 — intervention group
Group type: COMPARATOR
Intervention: Focused Worry (FW) (instructions to not avoid naturally occurring worry for 2 weeks)
Number of subjects: 53
Study 22977265 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus Control (SC) training
Number of subjects: 53
Study 22977265 — intervention group
Group type: COMPARATOR
Intervention: Focused Worry (FW)
Number of subjects: 53
Study 16320005 — intervention group
Group type: EXPERIMENTAL
Intervention: Seprafilm
Number of subjects: 1701
Study 16320005 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 1701
Study 16320005 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1701
Study 12879225 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative brace locked in full extension for the first week (Group B)
Number of subjects: 36
Study 12879225 — intervention group
Group type: COMPARATOR
Intervention: Post-operative brace locked from 0 degrees to 90 degrees (Group A)
Number of subjects: 36
Study 12879225 — intervention group
Group type: EXPERIMENTAL
Intervention: KT 1000 arthrometric assessment
Number of subjects: 36
Study 10600433 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents as sole agents of change (experimental group)
Number of subjects: 60
Study 10600433 — intervention group
Group type: COMPARATOR
Intervention: Children as sole agents of change (conventional group)
Number of subjects: 60
Study 7813267 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine (A)
Number of subjects: 9
Study 7813267 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 9
Study 2009851 — intervention group
Group type: EXPERIMENTAL
Intervention: Four units of alcohol (approx. 70 mg alcohol/100 ml blood)
Number of subjects: 8
Study 2009851 — intervention group
Group type: EXPERIMENTAL
Intervention: Two units of alcohol (approx. 35 mg alcohol/100 ml blood)
Number of subjects: 8
Study 2009851 — intervention group
Group type: EXPERIMENTAL
Intervention: Nil units of alcohol (less than 5 mg alcohol/100 ml blood)
Number of subjects: 8
Study 2009851 — intervention group
Group type: COMPARATOR
Intervention: Control (no alcohol)
Number of subjects: 8
Study 7136544 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 15
Study 7136544 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 30085990 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial balance dialogue (PBD) group using Steno Balance Cards
Number of subjects: 92
Study 30085990 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC) group
Number of subjects: 92
Study 27929673 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadoxetate disodium (10 mL diluted 1:1 with saline; injection rate, 2 mL/s)
Number of subjects: 107
Study 27929673 — intervention group
Group type: COMPARATOR
Intervention: Gadobenate dimeglumine (0.2 mL/kg; maximum, 20 mL; injection rate, 2 mL/s)
Number of subjects: 107
Study 27929673 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadoxetate disodium
Number of subjects: 107
Study 26008133 — intervention group
Group type: EXPERIMENTAL
Intervention: (3)He MRI with abnormally elevated ventilation defect percent (VDP)
Number of subjects: 60
Study 26008133 — intervention group
Group type: COMPARATOR
Intervention: Normal VDP
Number of subjects: 60
Study 26008133 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of whole lung and lobar VDP with regional (3)He ADC
Number of subjects: 60
Study 26008133 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional VDP correlation with CT airway morphology measurements
Number of subjects: 60
Study 22673738 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrolides
Number of subjects: 0
Study 22673738 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose macrolides
Number of subjects: 0
Study 22673738 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 21384253 — intervention group
Group type: EXPERIMENTAL
Intervention: Homogenised spinach (225 g/day/person)
Number of subjects: 8
Study 19136455 — intervention group
Group type: EXPERIMENTAL
Intervention: Destruction of lesions
Number of subjects: 0
Study 19136455 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic only operation
Number of subjects: 0
Study 19136455 — intervention group
Group type: EXPERIMENTAL
Intervention: Excisional surgery for rectovaginal endometriosis
Number of subjects: 0
Study 19136455 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative surgery for symptomatic endometriosis
Number of subjects: 0
Study 16364015 — intervention group
Group type: EXPERIMENTAL
Intervention: LIF concentration in pregnant women (42 patients)
Number of subjects: 120
Study 16364015 — intervention group
Group type: COMPARATOR
Intervention: LIF concentration in non-pregnant women (66 patients)
Number of subjects: 120
Study 16364015 — intervention group
Group type: EXPERIMENTAL
Intervention: LIF concentration in women with ongoing pregnancy (34 ongoing pregnancy)
Number of subjects: 120
Study 16364015 — intervention group
Group type: COMPARATOR
Intervention: LIF concentration in women with miscarriage (8 miscarriage)
Number of subjects: 120
Study 15342304 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 145
Study 15342304 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 145
Study 15342304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 10899371 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg oral naltrexone
Number of subjects: 22
Study 10899371 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 9017547 — intervention group
Group type: EXPERIMENTAL
Intervention: Tea bag compress
Number of subjects: 65
Study 9017547 — intervention group
Group type: EXPERIMENTAL
Intervention: Water compress
Number of subjects: 65
Study 9017547 — intervention group
Group type: COMPARATOR
Intervention: No compress
Number of subjects: 65
Study 8393676 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 61
Study 8393676 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA)
Number of subjects: 61
Study 8393676 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study 2434792 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 1.25 mg p.o. q.d.
Number of subjects: 12
Study 2434792 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 5.0 mg p.o. q.d.
Number of subjects: 12
Study 2434792 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo not explicitly mentioned)
Number of subjects: 12
Study 2434792 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril (both doses)
Number of subjects: 12
Study 2434792 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril
Number of subjects: 12
Study 29075824 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (Arm B)
Number of subjects: 27
Study 29075824 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (Arm E)
Number of subjects: 27
Study 29075824 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Bevacizumab and Everolimus (dual-therapy)
Number of subjects: 27
Study 29075824 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-therapy in normal liver (Arm E)
Number of subjects: 27
Study 29075824 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-therapy in normal liver (Arm B)
Number of subjects: 27
Study 26541479 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 18
Study 26541479 — intervention group
Group type: COMPARATOR
Intervention: Local infiltration analgesia (LIA)
Number of subjects: 18
Study 26541479 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 24726190 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple and advanced methods of gait assessment
Number of subjects: 21
Study 24726190 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation program (11 weeks)
Number of subjects: 21
Study 23789281 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia with off-pump surgery
Number of subjects: 82
Study 23789281 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined general and high thoracic epidural anesthesia with off-pump surgery
Number of subjects: 82
Study 23789281 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia with on-pump surgery
Number of subjects: 82
Study 23789281 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined general and high thoracic epidural anesthesia with on-pump surgery
Number of subjects: 82
Study 20002546 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of the REFLECT statement for livestock trials
Number of subjects: 24
Study 20002546 — intervention group
Group type: EXPERIMENTAL
Intervention: Modification of CONSORT checklist items
Number of subjects: 24
Study 20002546 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based survey conducted before the meeting
Number of subjects: 24
Study 19015462 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized lecture about colon cancer lymph node assessment delivered by an expert opinion leader
Number of subjects: 42
Study 19015462 — intervention group
Group type: EXPERIMENTAL
Intervention: Academic detailing of a local opinion leader and a toolkit
Number of subjects: 42
Study 19015462 — intervention group
Group type: COMPARATOR
Intervention: Control group (21 hospitals) receiving only the standardized lecture
Number of subjects: 42
Study 16882058 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg/day naftopidil (Group LD)
Number of subjects: 153
Study 16882058 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg/day naftopidil (Group HD)
Number of subjects: 153
Study 16882058 — intervention group
Group type: COMPARATOR
Intervention: Control (not applicable)
Number of subjects: 153
Study 14661012 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1500 mg, starting the evening before angiography and given every 12 hours for 4 doses
Number of subjects: 96
Study 14661012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 14661012 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 96
Study 14661012 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) and Placebo
Number of subjects: 96
Study 10721816 — intervention group
Group type: EXPERIMENTAL
Intervention: PVX (plasma volume expansion with dextran (6%) or Pentaspan (10%))
Number of subjects: 8
Study 10721816 — intervention group
Group type: EXPERIMENTAL
Intervention: PVX
Number of subjects: 8
Study 10721816 — intervention group
Group type: COMPARATOR
Intervention: CON (control condition)
Number of subjects: 8
Study 10721816 — intervention group
Group type: COMPARATOR
Intervention: PVX and CON
Number of subjects: 8
Study 8795667 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine aspirin 900 mg
Number of subjects: 15
Study 8795667 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg
Number of subjects: 15
Study 8795667 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium salicylate 800 mg
Number of subjects: 15
Study 8795667 — intervention group
Group type: EXPERIMENTAL
Intervention: 9.5% saline with indomethacin 50 mg
Number of subjects: 15
Study 8795667 — intervention group
Group type: COMPARATOR
Intervention: 3% saline
Number of subjects: 15
Study 8795667 — intervention group
Group type: COMPARATOR
Intervention: 10% saline
Number of subjects: 15
Study 1479532 — intervention group
Group type: EXPERIMENTAL
Intervention: Various design and analysis methods in periodontal clinical trials
Number of subjects: 0
Study 6600677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6600677 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac 200 mg
Number of subjects: 12
Study 6600677 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 250 mg
Number of subjects: 12
Study 6600677 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 375 mg
Number of subjects: 12
Study 30878329 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard training plus additional weekly simulation training
Number of subjects: 0
Study 30878329 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard training plus additional weekly simulation training (standardized to supervisor's performance)
Number of subjects: 0
Study 28366341 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy including parent involved play (CBT-PIP)
Number of subjects: 90
Study 28366341 — intervention group
Group type: COMPARATOR
Intervention: Non-directive treatment (TEPT; triadic expressive play therapy)
Number of subjects: 90
Study 27092916 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A injection prior to implant placement
Number of subjects: 26
Study 27092916 — intervention group
Group type: COMPARATOR
Intervention: No Botulinum toxin type A injection (Control group)
Number of subjects: 26
Study 24703078 — intervention group
Group type: EXPERIMENTAL
Intervention: BROADLINE(®) at 0.12 mg/kg body weight
Number of subjects: 16
Study 24703078 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated cats)
Number of subjects: 16
Study 22116799 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrolide antibiotics (e.g., erythromycin, azithromycin)
Number of subjects: 235
Study 22116799 — intervention group
Group type: COMPARATOR
Intervention: No macrolide antibiotics (Control)
Number of subjects: 235
Study 22116799 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrolide antibiotics
Number of subjects: 235
Study 22116799 — intervention group
Group type: COMPARATOR
Intervention: Fluoroquinolone antibiotics (n = 90)
Number of subjects: 235
Study 22116799 — intervention group
Group type: COMPARATOR
Intervention: Cephalosporin antibiotics (n = 93)
Number of subjects: 235
Study 20661811 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 100
Study 20661811 — intervention group
Group type: COMPARATOR
Intervention: Placebo training
Number of subjects: 100
Study 17612356 — intervention group
Group type: EXPERIMENTAL
Intervention: CAI-rehab (rehabilitation program for CAI)
Number of subjects: 48
Study 17612356 — intervention group
Group type: COMPARATOR
Intervention: CAI-control (control group)
Number of subjects: 48
Study 17612356 — intervention group
Group type: COMPARATOR
Intervention: Healthy group
Number of subjects: 48
Study 15258224 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (15 Hz rTMS for 10 days)
Number of subjects: 42
Study 15258224 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine 20 mg/day
Number of subjects: 42
Study 12465006 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction with internal fixation (ORIF) and intermaxillary wire fixation (IMF)
Number of subjects: 31
Study 12465006 — intervention group
Group type: COMPARATOR
Intervention: Open reduction with internal fixation (ORIF) without intermaxillary wire fixation (IMF)
Number of subjects: 31
Study 12465006 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups (ORIF with IMF and ORIF without IMF)
Number of subjects: 31
Study 10211915 — intervention group
Group type: EXPERIMENTAL
Intervention: Trihexyphenidyl (THP) dose reduction by 1 mg every 2 weeks
Number of subjects: 75
Study 10211915 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dose reduction)
Number of subjects: 75
Study 8561482 — intervention group
Group type: EXPERIMENTAL
Intervention: Neophilic model (who chose mostly novel foods)
Number of subjects: 0
Study 8561482 — intervention group
Group type: EXPERIMENTAL
Intervention: Neophobic model (who chose mostly familiar foods)
Number of subjects: 0
Study 8561482 — intervention group
Group type: COMPARATOR
Intervention: No model
Number of subjects: 0
Study 8561482 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to neophilic model
Number of subjects: 0
Study 8561482 — intervention group
Group type: EXPERIMENTAL
Intervention: Modeling manipulation
Number of subjects: 0